183 related articles for article (PubMed ID: 26687194)
1. Clinical and biological significance of PIM1 kinase in osteosarcoma.
Liao Y; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
J Orthop Res; 2016 Jul; 34(7):1185-94. PubMed ID: 26687194
[TBL] [Abstract][Full Text] [Related]
2. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of PIM kinases in osteosarcoma.
Mou S; Wang G; Ding D; Yu D; Pei Y; Teng S; Fu Q
Int J Oncol; 2016 Nov; 49(5):2116-2126. PubMed ID: 27826617
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PIM1 kinase attenuates inflammation-induced pro-labour mediators in human foetal membranes in vitro.
Lim R; Barker G; Lappas M
Mol Hum Reprod; 2017 Jun; 23(6):428-440. PubMed ID: 28333279
[TBL] [Abstract][Full Text] [Related]
5. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1.
Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y
Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304
[TBL] [Abstract][Full Text] [Related]
6. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.
Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF
Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186
[TBL] [Abstract][Full Text] [Related]
7. PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2/STAT3 pathway.
Kuang X; Xiong J; Wang W; Li X; Lu T; Fang Q; Wang J
Life Sci; 2019 Feb; 219():248-256. PubMed ID: 30658101
[TBL] [Abstract][Full Text] [Related]
8. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Brasó-Maristany F; Filosto S; Catchpole S; Marlow R; Quist J; Francesch-Domenech E; Plumb DA; Zakka L; Gazinska P; Liccardi G; Meier P; Gris-Oliver A; Cheang MC; Perdrix-Rosell A; Shafat M; Noël E; Patel N; McEachern K; Scaltriti M; Castel P; Noor F; Buus R; Mathew S; Watkins J; Serra V; Marra P; Grigoriadis A; Tutt AN
Nat Med; 2016 Nov; 22(11):1303-1313. PubMed ID: 27775704
[TBL] [Abstract][Full Text] [Related]
9. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
Lin YW; Beharry ZM; Hill EG; Song JH; Wang W; Xia Z; Zhang Z; Aplan PD; Aster JC; Smith CD; Kraft AS
Blood; 2010 Jan; 115(4):824-33. PubMed ID: 19965690
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor.
Yi X; Cao Z; Yuan Y; Li W; Cui X; Chen Z; Hu X; Yu A
J Control Release; 2021 Apr; 332():434-447. PubMed ID: 33662457
[TBL] [Abstract][Full Text] [Related]
11. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
12. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
13. PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium.
Takeuchi H; Miyamoto T; Fuseya C; Asaka R; Ida K; Ono M; Tanaka Y; Shinagawa M; Ando H; Asaka S; Shiozawa T
Int J Gynecol Pathol; 2023 May; 42(3):282-292. PubMed ID: 35443252
[TBL] [Abstract][Full Text] [Related]
14. ROCK1 as a potential therapeutic target in osteosarcoma.
Liu X; Choy E; Hornicek FJ; Yang S; Yang C; Harmon D; Mankin H; Duan Z
J Orthop Res; 2011 Aug; 29(8):1259-66. PubMed ID: 21387396
[TBL] [Abstract][Full Text] [Related]
15. Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.
Herzog S; Fink MA; Weitmann K; Friedel C; Hadlich S; Langner S; Kindermann K; Holm T; Böhm A; Eskilsson E; Miletic H; Hildner M; Fritsch M; Vogelgesang S; Havemann C; Ritter CA; Meyer zu Schwabedissen HE; Rauch B; Hoffmann W; Kroemer HK; Schroeder H; Bien-Möller S
Neuro Oncol; 2015 Feb; 17(2):223-42. PubMed ID: 25155357
[TBL] [Abstract][Full Text] [Related]
16. Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.
Yan B; Yau EX; Samanta S; Ong CW; Yong KJ; Ng LK; Bhattacharya B; Lim KH; Soong R; Yeoh KG; Deng N; Tan P; Lam Y; Salto-Tellez M;
Gastric Cancer; 2012 Apr; 15(2):188-97. PubMed ID: 21993851
[TBL] [Abstract][Full Text] [Related]
17. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
18. PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
Brault L; Menter T; Obermann EC; Knapp S; Thommen S; Schwaller J; Tzankov A
Br J Cancer; 2012 Jul; 107(3):491-500. PubMed ID: 22722314
[TBL] [Abstract][Full Text] [Related]
19. PIM1 kinase as a target for cancer therapy.
Merkel AL; Meggers E; Ocker M
Expert Opin Investig Drugs; 2012 Apr; 21(4):425-36. PubMed ID: 22385334
[TBL] [Abstract][Full Text] [Related]
20. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
